» Articles » PMID: 20467781

Streptomyces and Saccharopolyspora Hosts for Heterologous Expression of Secondary Metabolite Gene Clusters

Overview
Specialty Biotechnology
Date 2010 May 15
PMID 20467781
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Natural products discovery from actinomycetes has been on the decline in recent years, and has suffered from a lack of innovative ways to discover new secondary metabolites within a background of the thousands of known compounds. Recent advances in whole genome sequencing have revealed that actinomycetes with large genomes encode multiple secondary metabolite pathways, most of which remain cryptic. One approach to address the expression of cryptic pathways is to first identify novel pathways by bioinformatics, then clone and express them in well-characterized hosts with known secondary metabolomes. This process should eliminate the tedious dereplication process that has hampered natural products discovery. Several laboratory and industrial production strains have been used for heterologous production of secondary metabolite pathways. This review discusses the results of these studies, and the pros and cons of using various Streptomyces and one Saccharopolyspora strain for heterologous expression. This information should provide an experimental basis to help researchers choose hosts for current application and future development to express heterologous secondary metabolite pathways in yields sufficient for rapid scale-up, biological testing, and commercial production.

Citing Articles

Diversity of secondary metabolites from marine Streptomyces with potential anti-tubercular activity: a review.

Patel S, Naik L, Rai A, Palit K, Kumar A, Das M Arch Microbiol. 2025; 207(3):64.

PMID: 39961874 DOI: 10.1007/s00203-024-04233-8.


When synthetic biology meets medicine.

Feng Y, Su C, Mao G, Sun B, Cai Y, Dai J Life Med. 2025; 3(1):lnae010.

PMID: 39872399 PMC: 11749639. DOI: 10.1093/lifemedi/lnae010.


Engineering the TetR-family transcriptional regulator XNR_0706 to enhance heterologous spinosad production in B4 chassis.

Cui X, Tang H, Wang W, Wei W, Wu J, Ye B Synth Syst Biotechnol. 2024; 10(1):218-225.

PMID: 39582691 PMC: 11584518. DOI: 10.1016/j.synbio.2024.08.008.


Actinomycetes as Producers of Biologically Active Terpenoids: Current Trends and Patents.

Tarasova E, Luchnikova N, Grishko V, Ivshina I Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375819 PMC: 10301674. DOI: 10.3390/ph16060872.


Bacteria as genetically programmable producers of bioactive natural products.

Hug J, Krug D, Muller R Nat Rev Chem. 2023; 4(4):172-193.

PMID: 37128046 DOI: 10.1038/s41570-020-0176-1.


References
1.
Matsushima P, Baltz R . A gene cloning system for 'Streptomyces toyocaensis'. Microbiology (Reading). 1996; 142 ( Pt 2):261-267. DOI: 10.1099/13500872-142-2-261. View

2.
Binnie C, Warren M, Butler M . Cloning and heterologous expression in Streptomyces lividans of Streptomyces rimosus genes involved in oxytetracycline biosynthesis. J Bacteriol. 1989; 171(2):887-95. PMC: 209679. DOI: 10.1128/jb.171.2.887-895.1989. View

3.
Tetzlaff C, You Z, Cane D, Takamatsu S, Omura S, Ikeda H . A gene cluster for biosynthesis of the sesquiterpenoid antibiotic pentalenolactone in Streptomyces avermitilis. Biochemistry. 2006; 45(19):6179-86. PMC: 2518623. DOI: 10.1021/bi060419n. View

4.
Bibb M, Hesketh A . Chapter 4. Analyzing the regulation of antibiotic production in streptomycetes. Methods Enzymol. 2009; 458:93-116. DOI: 10.1016/S0076-6879(09)04804-6. View

5.
Epp J, Burgett S, Schoner B . Cloning and nucleotide sequence of a carbomycin-resistance gene from Streptomyces thermotolerans. Gene. 1987; 53(1):73-83. DOI: 10.1016/0378-1119(87)90094-1. View